247.80000 EUR
4.1
1.63%
Last update Dec 15, 9:57 PM CET
Main market
Day range
247.80000
250.80000
Previous close
251.89999
Open
250.80000
Access this stock data via API
Subscribe
Insulet Corporation
247.80
4.10
1.63%

Overview

Access /time_series data via our API — starting from the Basic plan.

Description

Insulet Corporation is a leading medical device company specializing in innovative insulin management systems for people with diabetes. Founded in 2000 and headquartered in Acton, Massachusetts, Insulet is renowned for its Omnipod system—a tubeless, wearable insulin pump that delivers continuous insulin without the need for multiple daily injections. The company’s products enhance diabetes care by simplifying insulin administration, offering greater freedom and improved quality of life to users globally. Insulet serves a diverse international market, with availability in 25 countries and over 500,000 customers worldwide. Its commitment to advancing diabetes technology is supported by continuous research and development, aiming to refine and expand its product offerings. Insulet plays a significant role in the healthcare sector, particularly within the medical device industry, by providing cutting-edge solutions that address the complex needs of insulin-dependent individuals while emphasizing sustainability and social responsibility.

About

CEO
Ms. Ashley A. McEvoy
Employees
3900
Address
100 Nagog Park
Acton, 01720, MA
United States
Phone
978 600 7000
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Medical Devices
Country
Germany
MIC code
XFRA
Access /profile data via our API — starting from the Grow plan.
Main market

Exchange is currently active.
Closing in 7 hours 47 minutes

14:12
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).